Pillstats
Rx only · Tablet · Oral

Amlodipine And Olmesartan Medoxomil

Amlodipine Besylate + Olmesartan Medoxomil

3 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US9 NDCs
3 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATC
RxCUI (US)
US makers3 labelers
Packages26
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 16 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.088$0.177$0.265$0.354Dec 2025Mar 2026Jun 2026
$0.287
Latest avg · Jun 17, 2026
-5%
Since Dec 17, 2025
3
Active US suppliers
92%
Top-2 supplier share*

Who makes it3 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Micro Labs Limitedunknown16SUPPLYING
Ascend Laboratories, LLCunknown8SUPPLYING
Bryant Ranch Prepackrepackager2SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.